Answers are grounded in this paper and cite their sources.
Objective: Cannabidiol (CBD) possesses considerable anti-inflammatory and antioxidant activities; however, its pharmaceutical application is hindered by its extremely low aqueous solubility (<0.1 μg/mL). This study aimed to improve the solubility of CBD through β-cyclodextrin (β-CD) inclusion complexation combined with polymeric micelles formation and to develop a CBD-loaded hyaluronic acid (HA) hydrogel delivery system.Materia and Methods: Water-soluble CBD formulations were prepared through β-CD inclusion complexation combined with poloxamer 407-based polymeric micelle formation, followed by lyophilization. The resulting powder was subsequently incorporated into HA-based hydrogels. Solid-state characteristics were investigated using differential scanning calorimetry (DSC), Fourier transform infrared (FT-IR) spectroscopy, and powder X-ray diffraction (PXRD). Physicochemical properties, including particle size, polydispersity index (PDI), and zeta potential, were determined. Rheological properties and gelation were evaluated using a stress-controlled rheometer. In vitro CBD release was assessed using a dialysis bag diffusion method in phosphate buffer solution (PBS, pH 7.4) at 35±1 °C.Results: The aqueous solubility of CBD was markedly enhanced to 2.5 mg/mL, representing a 4,275-fold increase compared with native CBD. Solid-state characterization confirmed the transformation of crystalline CBD and the formation of a new phase. The developed hydrogels exhibited particle sizes ranging from 558.6 to 2,905.3 nm and showed a more negative zeta potential than the blank hydrogel formulation. All formulations demonstrated shear-thinning rheological behavior, whereas gelation at 15.9 °C was observed only in the blank hydrogel. In vitro release studies revealed that most formulations released CBD within 45–60 minutes.Conclusion: The β-CD–poloxamer system effectively enhanced the aqueous solubility of CBD and enabled its stable incorporation into an HA-based hydrogel matrix. The developed formulation demonstrates promising potential as a versatile platform for CBD-based drug delivery applications.
No takes yet. Share an insight, caveat, or question.
Srakhao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: